Monkeypox: ECDC publishes rapid risk assessment
The European Centre for Disease Prevention and Control (ECDC) has published a rapid risk assessment following an outbreak of monkeypox (MPX), affecting the UK, EU/EEA countries, and North America.
The focus of ECDC’s MPX assessment is centred on human-to-human transmission and, to date, EFSA is not aware of any reports of infections in animals (pets or wild animals) in the EU. There is a possible risk of human-to-animal transmission in Europe, therefore close collaboration between human and veterinary public health authorities is needed to manage exposed pets and prevent the disease from being transmitted to wildlife.
EFSA’s experts are following the progress of the MPX outbreak closely with a focus on the possibility of human-to-animal spillover in the EU.
Read the ECDC rapid risk assessment monkeypox multi-country outbreak from 23 May 2022
This page was updated on 23 June to remove the Q&A. The updated Q&A are available on the topic page Monkeypox.
How to contact us
EFSA Media Relations Office
Tel. +39 0521 036 149
E-mail: press [at] efsa.europa.eu
(Only if you are a member of the press)
Ask a Question Service
You have a question about EFSA’s work? Contact our Ask a Question service!